Events

Sign Up To Attend Free ODAC Virtual Workshops

By January 13, 2021No Comments

Dermatology Events

Events

Sign up now to attend Free ODAC Virtual 2021 Workshops

Sign up now to attend Free ODAC Virtual 2021 Workshops

The virtual ODAC conference, taking place January 14 – 17, 2021 is offering free workshops throughout the week.

Dermatologists do not need to be registered to attend ODAC to join the workshops, however, to attend, you must preregister for each session. View the workshop agenda below to save your spot.

To view the entire ODAC Conference agenda, click here.

  • In His Own Words: One Patient’s Journey with Dr. Alvaro Moreira

  • Wednesday, January 13th 7:00 PM ET
Sign Up Now
  • FDA Approved Label Expansion. Progress Your Topical Patients to the Next Step: An Oral Treatment With Data for Moderate to Severe Scalp Psoriasis with Lawrence Green, MD

  • Thursday, January 14th 7:15 PM ET
Sign Up Now
  •  ARAZLO™ Lotion: Tazarotene Redefined with Leon Kircik, MD

  • Friday, January 15th 12:00 PM ET
Sign Up Now
  • Behind the Brand – The DNA of La Roche-Posay with Adam Friedman, MD

  • Friday, January 15th 3:15 PM ET
Sign Up Now
  • Pathophysiology of Atopic Dermatitis with Marc Serota, MD, FAAD

  • Saturday, January 16th 12:00 PM ET
Sign Up Now

You May Also Like

Touching on Tailored Topical for Tons of Tough Treatment Tchallenges

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Journal of Drugs in Dermatology JDD About Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

| Featured Articles, Latest News, Psoriasis, The Latest | No Comments
Did you miss this March article? Generalized pustular psoriasis (GPP) is a serious and unpredictable skin condition with limited treatment options. The Effisayil 1 trial evaluated spesolimab, a monoclonal antibody…
Journal of Drugs in Dermatology JDD About Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

| Featured Articles, Latest News, Oncodermatology, The Latest | No Comments
Prioritizing Skincare in Cancer Treatment: A Latin American Initiative Cancer treatments often lead to skin-related side effects that impact quality of life and, in some cases, treatment adherence. The Latin…

Leave a Reply